Hepatitis C Virus 2024: From Prevention to Management 

Nov 16 2024
Convention Center: Room 29
2:00 PM - 3:30 PM
Captured

World Class Speakers

Carolyn Wester, MD, MPH
Presenter

Carolyn Wester, MD, MPH

CDC, Division of Viral Hepatitis
DB
Presenter

Debika Bhattacharya, MD, MSc

UCLA
Brian Pearlman, MD, FAASLD, FACP, AAHIVS
Presenter

Brian Pearlman, MD, FAASLD, FACP, AAHIVS

Emory/Medical College of Georgia
JL
Presenter

Jake Liang
PP
Moderator

Ponni V. Perumalswami, MD, FAASLD

University of Michigan Medical Center

Description

Experts review and discuss the most up-to-date information on rapid, point-of-care HCV diagnostic strategies; HCV vaccine development and its importance in achieving the goal of HCV elimination; and the management of special populations with chronic HCV infection including difficult-to-treat or hard-to-reach persons.

Journey Maps

Objectives

  • Review available technologies for point-of-care HCV testing and their successful implementation in the United States and other countries.
  • Discuss treatment and retreatment strategies with direct-acting antivirals in difficult-to-treat or hard-to-reach HCV-infected persons.
  • Analyze the role of HCV vaccine development in achieving HCV elimination.
Chair

Harrys A Torres, MD, FAASLD

The University of Texas MD Anderson Cancer Center